drugset / Trial / NCT06152991
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
the purpose of this clinical trial is to assess the efficacy and safety of Orotic Acid Carnitine Complex Capsules (Godex®) in comparison to a placebo control group in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Timeline
- Start
- 2023-09-25
- Primary completion
- 2026-06-30
- Completion
- 2027-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GODEX | Unknown | — | Oral |